NCF2 and metabolic dysfunction-associated steatohepatitis: Comparable to the LDLRKO NASH model, hepatic CD8+ T cells from the Tac NASH model also demonstrated significant increases in CD8+ T cell activation and proliferation when exposed to the Ncf2 peptide compared to NP control by day 3 (Supplementary Figures 7A, B).